A r t i c l e s
Type 1 regulatory T cells (Tr1 cells) have emerged as an important subset of CD4 + T cells that help to control excessive inflammatory responses 1 . The anti-inflammatory effects of Tr1 cells rely on their secretion of interleukin 10 (IL-10), which dampens the function of antigen-presenting cells and antigen-specific effector T cells to suppress tissue inflammation and autoimmunity. However, progress in the molecular analysis and understanding of the biological functions of Tr1 cells has been hampered by the lack of appropriate methods for generating large numbers of IL-10-producing T cells in vitro.
IL-27, a heterodimeric cytokine of the IL-12 family, was initially suggested to induce the expansion of proinflammatory T helper type 1 (T H 1) cells by activating the transcription factors STAT1 and T-bet, similarly to . However, mice that lack the IL-27 receptor (Il27ra −/− mice) develop exaggerated proinflammatory T cell responses 3 and autoimmunity 4 , which suggests that IL-27 might be directly involved in the inhibition of tissue inflammation. Indeed, IL-27 has been shown to be a growth and differentiation factor for Tr1 cells [5] [6] [7] . The activation of naive CD4 + cells in the presence of IL-27 or transforming growth factor-β (TGF-β) plus IL-27 results in the differentiation of IL-10-producing Tr1 cells that can potently suppress inflammation and autoimmunity. In addition to its effects on the differentiation of Tr1 cells, IL-27 directly inhibits the differentiation of IL-17-producing helper T cells (T H 17 cells) 4, 8 and TGF-β-induced regulatory T cells (T reg cells) positive for the transcription factor Foxp3 (ref. 5) .
IL-27 drives the population expansion of Tr1 cells by inducing the expression of IL-21, a member of the IL-2 family of cytokines, which acts as an autocrine growth factor for Tr1 cells [9] [10] [11] . As with IL-10, IL-21 expression was initially reported to be specific for T H 2 cells 12 , but later studies showed that IL-21 is also produced by Tr1 cells 9 , T H 17 cells 13 and follicular helper T cells 14 . All these cell types produce IL-10, albeit in different amounts, which suggests that the production of IL-21 and of IL-10 might be linked. Even though IL-21 promotes the population expansion of T H 17 cells 15 , Il21r −/− mice, like Il27ra −/− mice, show greater susceptibility to experimental autoimmune encephalomyelitis (EAE), which indicates that IL-21 might have an important regulatory role in vivo 16 .
In an effort to delineate the molecular mechanisms by which IL-27 induces Tr1 cells, IL-27 was found to directly induce the transcription factor c-Maf, which is crucial for Tr1 cell differentiation 9 . In the absence of c-Maf, the generation and population expansion of Tr1 cells are compromised. Indeed, c-Maf directly transactivates the Il10 and Il21 promoters 9, 17 . Although these findings highlight the importance of c-Maf and IL-21 for the biology of Tr1 cells, the addition of recombinant IL-21 to naive CD4 + T cells alone fails to generate Tr1 cells, which suggests that additional IL-27-driven molecular signals contribute to Tr1 cell differentiation.
To explore the molecular mechanisms that account for the effects of IL-27 in Tr1 cell differentiation, we have analyzed the gene expression of IL-27-induced Tr1 cells and found that the ligand-activated transcription factor aryl hydrocarbon receptor (AhR) was induced by IL-27 in Tr1 cells. Furthermore, during Tr1 cell differentiation, AhR physically associated with c-Maf and transactivated the Il10 and Il21 A r t i c l e s promoters. Mice with impaired AhR signaling showed less production of IL-10 and resistance to IL-27-mediated inhibition of EAE. Together our results show that AhR and c-Maf act in synergy to induce IL-27-mediated Tr1 cell differentiation.
RESULTS

High expression of Ahr in IL-27-induced-Tr1 cells
We first studied Ahr expression by RT-PCR in various subsets of CD4 + T cells. Whereas the expression of Ahr was modest in T H 1 or T H 2 cells differentiated from naive CD4 + CD25 − CD62L + CD44 lo T cells, Ahr expression was very high in Tr1 cells induced with TGF-β and IL-27 (Fig. 1a) . The expression of Ahr in Tr1 cells was similar to that found in T H 17 cells, in which AhR controls IL-22 production 18, 19 .
We investigated the kinetics of Ahr expression during the differentiation of Tr1 cells with TGF-β and IL-27 and found that Ahr expression was substantially upregulated 12 h after the initiation of the culture and high expression was sustained throughout Tr1 cell differentiation (Fig. 1b) . Given that Tr1 cells can also be differentiated by IL-27 without TGF-β (ref. 9), we analyzed the kinetics of Ahr expression during the differentiation of Tr1 cells with IL-27 alone. Ahr expression was also induced by treatment with IL-27 alone, albeit at lower expression than that in cells induced by both IL-27 and TGF-β (Fig. 1b) . T cells activated without any polarizing cytokines (T H 0 condition) had only marginal expression of Ahr.
The expression of the xenobiotic metabolizing enzyme cytochrome P450, encoded by Cyp1a1, is directly controlled by the AhR, which transactivates the Cyp1a1 promoter 20 . To test whether the AhR is activated during Tr1 cell differentiation, we analyzed Cyp1a1 expression in naive CD4 + T cells treated with IL-27 with or without TGF-β. Cyp1a1 was expressed in CD4 + cells as early as 20 h after activation (Fig. 1c) . Tr1 cells that had been differentiated with IL-27 alone expressed Cyp1a1 transiently, whereas high Cyp1a1 expression was sustained in Tr1 cells that had been differentiated with TGF-β and IL-27 (Fig. 1c) .
The transcription factor c-Maf is important for Tr1 cell differentiation 9 . Therefore, we analyzed the expression of Ahr and Maf during the differentiation of Tr1 cells with TGF-β and IL-27. We detected Maf expression 6 h after the initiation of differentiation, whereas we first detected Ahr expression 8 h after differentiation and found it was lower than that of Maf. High expression of both Ahr and Maf was sustained after 24 h (Fig. 1d) . Overall, these studies show that Ahr, like Maf, is highly expressed and active during IL-27-triggered differentiation of Tr1 cells. 18, 19 . The high expression of Ahr during Tr1 cell differentiation led us to hypothesize that AhR ligands might also affect Tr1 cell differentiation. To investigate the effect of AhR signaling on Tr1 cell development, we differentiated naive CD4 + cells from Vert-X reporter mice expressing IL-10 linked to enhanced green fluorescent protein (eGFP) 21 using TGF-β and IL-27 in the presence of either of the AhR ligands TCDD and FICZ. Both TCDD and FICZ doubled the number of IL-10-producing T cells (Fig. 2a) and increased the secretion of IL-10 more than threefold over controls (Fig. 2b) , which suggested that activation of AhR promotes Tr1 cell differentiation. We obtained similar results when we induced differentiation with IL-27 alone ( Supplementary  Fig. 1 ). Although TCDD has been proposed to support the development of Foxp3 + T reg cells 19, 22 , the addition of AhR ligands together with IL-27 during Tr1 cell differentiation did not induce Foxp3 expression ( Supplementary Fig. 2 and data not shown), which rules out any possible involvement of Foxp3 + T reg cells in the enhanced IL-10 expression. These results are consistent with those of a study showing that FoxP3 is not induced in T reg cells generated by AhR ligands during graft-versus-host responses 23 . To further characterize the contribution of AhR to Tr1 cell differentiation, we knocked down Ahr expression using small inhibitory RNA (siRNA). We used TGF-β and IL-27 to differentiate Tr1 cells in the presence of siRNA specific for AhR or control siRNA and analyzed IL-10 expression by RT-PCR and flow cytometry. We found that naive T cells in which Ahr expression had been downregulated by siRNA were less able to produce IL-10 than were cells treated with control siRNA (Fig. 2c) . We obtained similar results when we knocked down Maf as a positive control. In agreement with our previous results, addition of the AhR antagonist CH-223191 during the differentiation of Tr1 cells with TGF-β plus IL-27 led to lower IL-10 production than that of cells differentiated without CH-223191 (Supplementary Fig. 3a) . Similarly, the ability of AhR-deficient T cells to differentiate into Tr1 cells in the presence of TGF-β plus IL-27 was impaired (Supplementary Fig. 3b ), which confirmed that AhR is essential for the differentiation of Tr1 cells. In summary, modulation of AhR signaling with the agonists FICZ or TCDD, the antagonist CH-223191, by siRNA-mediated downregulation or genetic deletion of Ahr profoundly affects the development of IL-10-producing Tr1 cells.
To confirm that AhR is involved in IL-10 expression, we retrovirally transduced primary CD4 + T cells with a bicistronic overexpression vector expressing Ahr and green fluorescent protein (Ahr-GFP) or an empty GFP-encoding control vector and monitored expression of IL-10 on GFP + cells. The expression of IL-10, but not of interferon-γ (IFN-γ), was substantially induced in primary CD4 + T cells that overexpressed A r t i c l e s AhR ( Supplementary Fig. 4 ). These results suggest that the IL-27-driven expression of AhR is responsible for the enhanced secretion of IL-10 during Tr1 cell differentiation. Given that c-Maf is essential for the generation of Tr1 cells 9 , we evaluated the relative contributions of c-Maf and AhR to the development of Tr1 cells. We differentiated naive T cells from mice overexpressing a Maf transgene under the control of the Cd4 promoter without any cytokine or with TGF-β plus IL-27. In addition, to activate AhR signaling, we added FICZ to Maf-transgenic T cells. In line with published reports 17 , overexpression of c-Maf was sufficient to drive IL-10 secretion by T H 0 cells (Fig. 2d) . As both TGF-β and IL-27 are required for AhR expression, FICZ alone did not alter the secretion of IL-10 from Maf-transgenic cells in the absence of TGF-β and IL-27. However, we found that T cells that overexpressed c-Maf secreted considerably more IL-10 after differentiation with TGF-β plus IL-27 and FICZ than did T cells without the transgene (Fig. 2d) , which suggested that the two transcription factors AhR and c-Maf act together to enhance IL-10 secretion from Tr1 cells.
AhR regulates IL-21 expression in Tr1 cells
IL-27 acts on Tr1 cells to trigger the production of IL-21, which acts as an autocrine growth factor for Tr1 cells 9 . Therefore, we examined the effect of AhR signaling on the production of IL-21 by Tr1 cells. We first differentiated naive CD4 + T cells with TGF-β plus IL-27 in the presence of FICZ and found that treatment with FICZ led to fourfold more IL-21 production by Tr1 cells than that of cells differentiated without FICZ (Fig. 3a) . Another AhR ligand, TCDD, had a similar effect ( Supplementary Fig. 5 ). 
A r t i c l e s
Because c-Maf regulates IL-21 production 9,14 , we examined Maf expression in Tr1 cells differentiated in the presence of AhR ligands. As well as enhancing IL-21 expression, AhR activation by FICZ during Tr1 cell differentiation led to the upregulation of Maf (Fig. 3b) . Treatment with FICZ or TCDD in the absence of differentiating cytokines had no effect on Maf expression ( Fig. 3b  and Supplementary Fig. 5 ), which indicated that AhR activation is not sufficient to upregulate Maf. Thus, AhR activation potentiates the expression of c-Maf and IL-21 during the differentiation of Tr1 cells triggered by IL-27. Naive CD4 + T cells from IL-21R-deficient mice have an impaired capacity to differentiate into Tr1 cells 9 . To test whether the effects of AhR activation on Tr1 cell differentiation were mediated by IL-21, we differentiated naive CD4 + T cells from Il21r −/− mice with TGF-β plus IL-27, with or without FICZ. IL-21 secretion was enhanced in FICZ-treated Tr1 cells from either wild-type or Il21r −/− mice (Fig. 3c) . However, IL-10 production was substantially impaired in Tr1 cells derived from Il21r −/− mice (Fig. 3d) . These results suggest that the effects of AhR activation on Tr1 cell differentiation are at least partly mediated by IL-21.
IL-21 is an autocrine Tr1 cell growth factor that enhances IL-10 and c-Maf expression in Tr1 cells 9 . Therefore, we investigated the effect of IL-21 on the expression of Maf and Ahr mRNA during Tr1 cell differentiation. In agreement with our previous findings, Maf expression in Tr1 cells was controlled by IL-21 signaling (Fig. 3e) . Strikingly, there was much lower Ahr expression in Tr1 cells derived from Il21r −/− mice than in cells from wild-type mice, whereas expression of mRNA for the transcription factor T-bet, which is induced by IL-27 during Tr1 cell differentiation 24 , was unaffected (Fig. 3e) . This suggests that as well as controlling c-Maf, IL-21 also modulates Tr1 cell development by inducing and/or maintaining AhR expression. Collectively, these results show that AhR signaling controls Tr1 cell differentiation in part by regulating IL-21 production, which in turn contributes to Tr1 cell development as a positive feedback mechanism, probably enhancing the expression of AhR mRNA and the production of IL-21 and IL-10.
AhR and c-Maf transactivate Il10 and Il21
It has been shown that c-Maf transactivates the Il10 and Il21 promoters 9, 17 . On the basis of our findings that the AhR has a key role in the regulation of IL-10 and IL-21 during Tr1 cell differentiation, we hypothesized that the AhR might transactivate the Il10 and Il21 promoters in Tr1 cells as well. We first searched the Il10 and Il21 promoters for AhR-and c-Maf-binding sites. We found one putative AhR-binding site (xenobiotic response element (XRE-1)) and four putative c-Maf-binding sites (Maf-recognition elements MARE-1, MARE-2, MARE-3 and MARE-4) in the Il10 promoter ( Fig. 4a and  Supplementary Fig. 6 ). Similarly, we identified two putative AhRbinding sites (XRE-2 and XRE-3) and three putative c-Maf-binding sites (MARE-5, MARE-6 and MARE-7) in the Il21 promoter ( Fig. 4a  and Supplementary Fig. 6 ).
To investigate whether AhR binds to XRE sequences in the Il10 and Il21 promoters, we monitored whether AhR translated in vitro would interact with an oligonucleotide containing the putative AhR-binding site located in the Il10 or Il21 promoter. As binding of AhR with AhR nuclear translocator (Arnt) transforms AhR into its high-affinity DNA-binding form 25 , we studied the binding of AhR in complex with Arnt to XRE-1, XRE-2 and XRE-3. We incubated the AhR-Arnt complex with a radiolabeled oligomer containing the putative AhRbinding site from the Il10 or Il21 promoter and visualized the AhRArnt-DNA protein complex by electrophoretic mobility-shift assay (Supplementary Fig. 7) . Binding of AhR to XRE sequences from the Il10 or Il21 promoter was inhibited by the inclusion of a competitor oligonucleotide containing the Cyp1a1 XRE3 AhR DNA-binding Fig. 7 ). To confirm that AhR can also interact with its target sequences in the Il10 and Il21 promoters under physiological conditions, we carried out chromatin immunoprecipitation (ChIP) assays using Tr1 cells differentiated in vitro with IL-27 and TGF-β. AhR interacted with XRE-1 in the Il10 promoter in both Tr1 and T H 0 cells and with XRE-2 and XRE-3 in the Il21 promoter in Tr1 cells (Fig. 4b,c and Supplementary Fig. 6 ). Similarly, ChIP assays showed that c-Maf interacted with MARE-1-MARE-4 and MARE-5-MARE-7 on the Il10 and Il21 promoters, respectively, but only in Tr1 cells (Fig. 4d,e and Supplementary Fig. 6 ). We found no interaction with the XRE or MARE sequences in either the Il10 or Il21 promoter when we used isotype-matched control antibodies (immunoglobulin G (IgG)), and we found no significant binding of AhR or c-Maf in the control sequence Untr6 (Fig. 4b-e) . These results suggest that c-Maf controls the cell specificity of the transcription of Il10 and Il21.
To determine the relevance of the binding of AhR and c-Maf to their target sequences in Il10 and Il21, we studied the ability of AhR and c-Maf to transactivate the Il10 and Il21 promoters in reporter assays. We used reporter constructs containing the firefly luciferase gene under the control of the Il10 promoter or the Il21 promoter. Cotransfection of the Il10 or Il21 luciferase reporter construct with a construct encoding mouse c-Maf resulted in slight upregulation of the transcription of Il10 and Il21 (Fig. 4f,g ). Transcription was similarly upregulated when we cotransfected the Il10 or Il21 luciferase reporter construct with a construct encoding mouse AhR (Fig. 4f,g) . Notably, cotransfection of c-Maf and AhR resulted in additive transactivation of the expression of both Il10 and Il21 (Fig. 4f,g ), which suggested that AhR and c-Maf act together to control the transcriptional activity of both promoters.
The concomitant upregulation of c-Maf and AhR during Tr1 cell differentiation (Fig. 1d) , their ability to bind to Il10 promoter elements to induce IL-10 secretion (Fig. 4) and the proximity of the putative binding sites for c-Maf and AhR on the Il10 and Il21 promoters led us to test whether c-Maf and AhR physically interact with each other. AhR interacts with diverse transcription factors, including NF-κB 27 and the estrogen receptor 28 . To address this issue, we differentiated naive CD4 + T cells into either T H 0 or Tr1 cells and immunoprecipitated proteins followed by immunoblot analysis. AhR and c-Maf were upregulated in Tr1 cells (Fig. 4h, left) . Moreover, we were able to precipitate c-Maf and AhR together in a Tr1 cell nuclear extract by using antibody to AhR (anti-AhR) to immunoprecipitate the complex, followed by immunoblot analysis with anti-c-Maf (Fig. 4h, right) , which suggested that AhR physically interacts with c-Maf. Together our results show that AhR and c-Maf interact in Tr1 cells to transactivate the Il10 and Il21 promoters.
AhR controls Tr1 cell generation in vivo
Repeated in vivo treatment with anti-CD3 induces IL-10 + T reg cells 29 . Given that we have shown that Ahr and Maf were induced after in vitro differentiation of Tr1 cells (Fig. 1) , we assumed that they might be similarly induced in vivo in IL-10 + T cells induced by treatment with anti-CD3. To test this, we repeatedly administered anti-CD3 or an isotype-matched control antibody to Vert-X reporter mice (expressing IL-10 linked to eGFP) and assessed Ahr and Maf expression in eGFP + IL-10-producing T cells in the spleen and mesenteric lymph nodes (MLNs) 4 h after the final injection. In line with our in vitro findings, both Ahr and Maf were substantially induced in IL-10 + T cells (Supplementary Fig. 8) 29 and Tr1 cells, we analyzed the production of IL-10 by Foxp3 − IL-17 − CD4 + CD3 + TCRαβ + T cells (Supplementary Fig. 9 ). The administration of anti-CD3 to wild-type mice resulted in significant induction of IL-10 + T cells in the spleen and the MLNs (Fig. 5) . The induction of IL-10-Dproducing cells in this setting was mediated by IL-27, as it was not present in anti-CD3-treated Il27ra −/− mice (Fig. 5) . In addition, Ahr d mice also showed a significant impairment in their ability to produce IL-10 + T cells, both in the spleen and the MLNs, after being treated with anti-CD3 (Fig. 5) . Thus, AhR controls the generation of IL-10 + T cells in vivo.
AhR controls the IL-27-mediated inhibition of EAE To address the in vivo relevance of AhR in inducing IL-27-driven Tr1 cells and its effect on regulating autoimmunity and tissue inflammation, we exploited an adoptive-transfer model of EAE in which IL-10, induced by IL-27, regulates EAE induced by adoptive transfer of T cells 7 . We used this model system to investigate the role of AhR in the in vivo suppressive activity of IL-27-induced IL-10 production. This model allowed us to exclude the effects of AhR on non-T R 1 T cells, as IL-27, when given in vivo, can also inhibit T H 17 and Foxp3 + T reg cell differentiation 5, 31 . We first immunized wild-type or Ahr d mice with the myelin oligodendrocyte peptide of amino acids 35-55 (MOG (35-55) ) emulsified in complete Freund's adjuvant and tested the secretion of IL-10 by CD4 + T cells reactivated with MOG(35-55) and IL-27. We observed significantly less production of IL-10 by CD4 + T cells from Ahr d mice treated with IL-27 (Fig. 6a) .
In line with published findings 7 , wild-type CD4 + T cells reactivated solely with MOG(35-55) were poor inducers of EAE (data not shown). However, reactivation of T cells in the presence of IL-12 before adoptive transfer generated MOG(35-55)-specific donor cells that induce EAE with high incidence 7 . We compared the secretion of IL-10 by donor cells obtained from MOG(35-55)-immunized wildtype or Ahr d mice that had been restimulated in vitro with IL-12 with or without IL-27. We found that IL-27 enhanced IL-10 production in wild-type T cells but not Ahr d T cells (Fig. 6b) . IL-27 did not affect the production of IFN-γ triggered by IL-12 (Fig. 6b) , and we did not detect notable amounts of IL-17 after stimulating donor cells with IL-12 and IL-27 (data not shown). We then adoptively transferred these cells into wild-type mice to induce EAE and found that wildtype effector cells reactivated in the presence of IL-12 induced disease in most recipient mice. The incidence of EAE was significantly lower for donor cells reactivated with IL-12 and IL-27 in vitro (Fig. 6c,d and Table 1 ). Ahr d donor T cells activated in the presence of IL-12 also induced EAE after adoptive transfer. However, the activation of Ahr d T cells in the presence of IL-27 resulted in a significantly greater incidence of disease than did wild-type T cells treated similarly (Fig. 6c,d and Tr1 cells are an important T reg cell type that produce mainly IL-10 and do not express Foxp3 but suppress tissue inflammation, graftversus-host disease and autoimmunity in an IL-10-dependent manner. Although IL-10 was initially described as a differentiation factor for Tr1 cells, IL-27 also generates IL-10-producing Tr1 cells 5, 8 . IL-27 induces both IL-10 and IFN-γ in T cells. These T cells, which produce both IL-10 and IFN-γ, have been reported to be generated in vivo after treatment with altered peptide ligands 32 EAE in wild type and mice treated as in Figure 6c . Disease incidence is presented as diseased mice/total mice; time of onset is presented as mean ± s.e.m.
*P < 0.05 (Fisher's exact test).
A r t i c l e s 36 . IL-22 is a member of the IL-10-related cytokine family 36 and might be regulated similarly. Therefore, our results raise the possibility that the interaction between c-Maf and AhR might control the production of not only IL-10 but also IL-22. Indeed, motif analysis has shown that the Il22 promoter, like the Il10 promoter, contains c-Maf-and AhR-binding sites in close proximity, which suggests that c-Maf and AhR might also act together to induce Il22 transcription.
Environmentally ubiquitous polycyclic aromatic and planar halogenated hydrocarbons, for which AhR is a cellular receptor, represent two important classes of environmental pollutants to which humans are regularly exposed. Endogenous ligands, although incompletely classified 37 , represent an additional category of AhR activators. Notably, exposure to polycyclic aromatic and planar halogenated hydrocarbons can result in contrasting AhR-dependent effects on the immune response. For example, TCDD-driven AhR activation enhances inflammation in rheumatoid arthritis 38 , and endogenous ligand-driven AhR activation induces production of inflammatory cytokines by T H 17 cells 18, 19 . However, prototypic polycyclic aromatic and planar halogenated hydrocarbons can impair B cell and T cell proliferative responses, alter antibody isotype switching, block plasma cell differentiation, compromise antibody production, induce apoptosis in developing lymphocytes, inhibit natural killer cell activity, modulate cytokine production, decrease cytotoxic T lymphocyte activity and promote tumor growth [39] [40] [41] [42] [43] [44] [45] [46] . In this context, our report, together with results by Gandhi et al. published in this issue of Nature Immunology 47 , provides evidence that the interaction of AhR with c-Maf is essential for the generation of mouse and human IL-10-secreting Tr1 cells that suppress inflammatory responses. These contrasting outcomes suggest that the in vivo immunological effects of AhR activation are tissue specific, ligand specific or both. In the context of autoimmunity, the outcome probably depends on the type of T cell-differentiation pathway activated by a given AhR ligand. As AhR and c-Maf are expressed in T H 17 cells 17 , Foxp3 + T reg cells and Tr1 cells 9 , it is unlikely that AhR alone or in combination with c-Maf acts as a specific 'lineage-specification' transcription factor for Tr1 cells. We instead postulate that AhR, in combination with c-Maf, controls parts of the Tr1 cell transcriptional and differentiation program. Thus, in response to different environmental ligands, AhR can induce opposing subsets of T cells in different ways, resulting in either tissue inflammation or immunosuppression. Therefore, although the molecular basis for the differences in the differentiation pathways favored by an AhR ligand (or more AhR ligands) is not clear, we predict that AhR ligands direct the nature of downstream signaling and thus provide specificity and dictate T cell subset dominance (Tr1 versus T H 17) during an immune response. In summary, we have shown that AhR, together with c-Maf, regulates the generation of Tr1 cells induced by IL-27. In addition to delineating the molecular mechanisms that account for the generation of Tr1 cells, our findings, together with other studies 18, 19 , suggest that AhR is not only a receptor for environmental pollutants but also an important target for regulating T cell differentiation and the quality of immune responses in vivo.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
